Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to rise 70.00% to -10 cents per share on August 19
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.28
Q2'24
Missed
by $0.02
The last earnings report on May 13 showed earnings per share of -5 cents, beating the estimate of -23 cents. With 152.09K shares outstanding, the current market capitalization sits at 468.60M.